Wells Fargo Maintains Overweight on Enovis, Lowers Price Target to $39

Benzinga · 1d ago
Wells Fargo analyst Larry Biegelsen maintains Enovis (NYSE:ENOV) with a Overweight and lowers the price target from $40 to $39.